The association of human papillomavirus vaccination with sexual behaviours and human papillomavirus knowledge: a systematic review

International Journal of STD and AIDS

Volumn 26, Issue 11, 2015, Pages 777-788

  Coles, Victoria AH ^a   Patel, Ajay S ^b   Allen, Felicity L ^b   Keeping, Sam T ^a   Carroll, Stuart M ^a  

^a Sanofi Pasteur MSD   (United Kingdom)

^b Decision Resources Group   (United Kingdom)

Author keywords

genital warts; HPV; Human papillomavirus; sexual behaviours; sexually transmitted infection; vaccination

Indexed keywords

WART VIRUS VACCINE;

AGE; COCHRANE LIBRARY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EMBASE; HUMAN; INFECTION PREVENTION; MEDLINE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PSYCINFO; REVIEW; SEXUAL BEHAVIOR; SYSTEMATIC REVIEW; UNSAFE SEX; VACCINATION; ADOLESCENT; ATTITUDE TO HEALTH; FEMALE; HIGH RISK BEHAVIOR; IMMUNOLOGY; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATIENT ATTITUDE; UTERINE CERVICAL NEOPLASMS;

ADOLESCENT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; RISK-TAKING; SEXUAL BEHAVIOR; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84942095583     PISSN: 09564624     EISSN: 17581052     Source Type: Journal    
DOI: 10.1177/0956462414554629     Document Type: Review

References (88)

1. M.GottvallT.TydenA.T.Hoglund. Knowledge of human papillomavirus among high school students can be increased by an educational intervention. Int J STD AIDS2010; 21: 558–562.
2. J.S.SmithL.LindsayB.Hoots. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer2007; 121: 621–632.
3. Sanofi Pasteur MSD Limited. Gardasil summary of product characteristics, http://www.medicines.org.uk/emc/medicine/19016 (2006, accessed 29 July 2014)
4. GlaxoSmithKline UK. Cervarix summary of product characteristics, http://www.medicines.org.uk/emc/medicine/20204 (2007, accessed 29 July 2014)
5. G.von Krogh. Management of anogenital warts (condylomata acuminata). Eur J Dermatol2001; 11: 598–603. quiz 04.
6. A.S.ForsterL.A.V.MarlowJ.Stephenson. Human papillomavirus vaccination and sexual behaviour: cross-sectional and longitudinal surveys conducted in England. Vaccine2012; 30: 4939–4944.
7. Public Health England. Annual HPV vaccine coverage in England 2012–13: by PCT and area team, https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/266207/HPV_AnnualDataTable2012_13_AT_acc5.pdf (2013, accessed 17 July 2014)
8. Australian Government DoHaA. The Australian immunisation handbook. 10th ed, http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/handbook10-4-6 (2013, accessed 25 September 2013)
9. Centers for Disease Control and Prevention. Morbidity and mortality weekly report. Recommendations on the use of quadrivalent human papillomavirus vaccine in males – advisory committee on immunization practices (ACIP), http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6050a3.htm (2011, accessed 25th September 2013)
10. A.S.ForsterL.A.V.MarlowJ.Waller. Adolescents' beliefs about their parents' human papillomavirus vaccination decisions. BJOG2010; 117: 229–233.
11. S.HiltonK.HuntM.Langan. Newsprint media representations of the introduction of the HPV vaccination programme for cervical cancer prevention in the UK (2005–2008). Soc Sci Med2010; 70: 942–950.
12. D.MoherA.LiberatiJ.Tetzlaff. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med2009; 6: e1000097–e1000097.
13. Centers for Disease CaP. National and state vaccination coverage among adolescents aged 13–17 years – United States, 2012. Morbidity Mortality Weekly Rep2013; 62: 685–708.
14. NICE Guidelines Manual 2009 criteria. Appendix D methodology checklist – randomised controlled trials, http://www.nice.org.uk/media/633/21/The_guidelines_manual_2009_-_Appendix_D_Methodology_checklist_-_randomised_controlled_trials.pdf (2009, accessed 4 July 2013)
15. D.ChambersM.RodgersN.Woolacott. Not only randomized controlled trials, but also case series should be considered in systematic reviews of rapidly developing technologies. J Clin Epidemiol2009; 62: 1253–1260 e4.
16. C.E.BaxterP.C.Barata. The paradox of HPV vaccines: how to reach sexually inexperienced women for protection against a sexually transmitted infection. Women's Health Issues2011; 21: 239–245.
17. I.JuraskovaR.A.BariM.T.O'Brien. HPV Vaccine promotion: does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior?Women's Health Issues2011; 21: 71–79.
18. M.GottvallM.LarssonA.T.Hoglund. High HPV vaccine acceptance despite low awareness among Swedish upper secondary school students HPV and upper secondary school students Gottvall et al. Eur J Contracep Reprod Health Care2009; 14: 399–405.
19. E.MarekT.DergezG.Rebek-Nagy. Effect of an educational intervention on Hungarian adolescents' awareness, beliefs and attitudes on the prevention of cervical cancer. Vaccine2012; 30: 6824–6832.
20. Kliewer EV, Mahmud SM, Demers AA, et al. HPV vaccination and cervical cancer screening behaviour in Manitoba, Canada. In: International papillomavirus conference (conference abstract), Berlin, 17–22 September 2011
21. L.BrabinS.A.RobertsR.Stretch. A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study. Br J Cancer2009; 101: 1502–1504.
22. R.De VisserL.WaitesC.Parikh. The importance of social norms for uptake of catch-up human papillomavirus vaccination in young women. Sex Health2011; 8: 330–337.
23. L.A.V.MarlowA.S.ForsterJ.Wardle. Mothers' and adolescents' beliefs about risk compensation following HPV vaccination. J Adolesc Health2009; 44: 446–451.
24. H.L.BowyerL.A.MarlowS.Hibbitts. Knowledge and awareness of HPV and the HPV vaccine among young women in the first routinely vaccinated cohort in England. Vaccine2013; 31: 1051–1056.
25. L.A.MarlowJ.WallerR.E.Evans. Predictors of interest in HPV vaccination: a study of British adolescents. Vaccine2009; 27: 2483–2488.
26. Cruickshank ME, Doogan F and Tucker J. Knowledge, beliefs and intended behaviour surrounding HPV vaccine and cervical screening in young adolescents since the introduction of UK HPV vaccine programme. In: International papillomavirus conference (conference abstract), San Juan, Puerto Rico, 30 November–6 December 2012
27. R.SacksA.RobinsonD.Wilkinson. Should sexual health services participate in the HPV vaccination programme? A national survey assessing HPV vaccination uptake in young GUM attendees. Br Assoc Sex Health HIV (conference abstract)2012; 88(Suppl 1): A4–A4.
28. Sadler L, Roberts S, Mandal D, et al. Risk and preventive behaviour amongst HPV vaccinated and unvaccinated young women. In: EUROGIN congress (conference abstract), Prague, Czech Republic, 8–11 July 2012
29. Sadler L, Roberts S, Schembri G, et al. Risk compensating sexual behaviour following vaccination against human papillomavirus. In: British Association for Sexual Health and HIV (conference abstract and full poster), Bristol, UK, 15–17 May 2013
30. P.A.AgiusM.K.PittsA.M.A.Smith. Human papillomavirus and cervical cancer: Gardasil vaccination status and knowledge amongst a nationally representative sample of Australian secondary school students. Vaccine2010; 28: 4416–4422.
31. B.GunasekaranY.JayasingheE.Moore. Knowledge of human papillomavirus (HPV) and the HPV vaccine among young women in Victoria, Australia who have been randomly recruited via facebook. J Pediatr Adolesc Gynecol2011; 24: e66–e67.
32. H.MarshallP.RyanD.Roberton. A cross-sectional survey to assess community attitudes to introduction of human papillomavirus vaccine. Aust N Z J Publ Health2007; 31: 235–242.
33. T.MatherK.McCafferyI.Juraskova. Does HPV vaccination affect women's attitudes to cervical cancer screening and safe sexual behaviour?Vaccine2012; 30: 3196–3201.
34. R.McNairJ.PowerS.Carr. Comparing knowledge and perceived risk related to the human papilloma virus among Australian women of diverse sexual orientations. Aust N Z J Publ Health2009; 33: 87–93.
35. D.SimatheraiC.S.BradshawC.K.Fairley. What men who have sex with men think about the human papillomavirus vaccine. Sex Transm Infect2009; 85: 148–149.
36. J.M.BrothertonR.M.Mullins. Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia. Cancer Epidemiol2012; 36: 298–302.
37. A.KrawczykE.LauS.Perez. What do they know and what do they think they know? The influence of knowledge and perceived knowledge on human papillomavirus (HPV) vaccination decision-making. Psycho-Oncology2011; 20: 295–296.
38. A.L.KrawczykS.PerezE.Lau. Human papillomavirus vaccination intentions and uptake in college women. Health Psychol2012; 31: 685–693.
39. C.RankM.GilbertG.Ogilvie. Acceptability of human papillomavirus vaccination and sexual experience prior to disclosure to health care providers among men who have sex with men in Vancouver, Canada: implications for targeted vaccination programs. Vaccine2012; 30: 5755–5760.
40. Burchell AN, Tellier PP, Coutlee F, et al. The effect of HPV vaccination on infection in partnerships. In: EUROGIN (conference abstract), Monte Carlo, Monaco, 17–20 February 2010
41. Lavoie F, Goggin P, Sauvageau C, et al. What do young women know, think and do about HPV prevention in Quebec Canada. In: International papillomavirus conference (conference abstract), Montreal, Canada, 3–8 July 2010
42. G.Di GiuseppeR.AbbateG.Liguori. Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. Br J Cancer2008; 99: 225–229.
43. C.P.PelulloG.Di GiuseppeI.F.Angelillo. Human papillomavirus infection: knowledge, attitudes, and behaviors among lesbian, gay men, and bisexual in Italy. PLoS One2012; 7: e42856–e42856.
44. F.SopracordevoleF.CigolotV.Gardonio. Teenagers' knowledge about HPV infection and HPV vaccination in the first year of the public vaccination programme. Eur J Clin Microbiol Infect Dis2012; 31: 2319–2325.
45. Sopracordevole F, Cigolot F and Petrillo E. What teens know about HPV infection and vaccination. In: EUROGIN congress (conference abstract), Monte Carlo, Monaco, 17–20 February 2010
46. Sopracordevole F and Cigolot F. Relation between vaccination status and teen's knowledge on HPV infection and vaccination. In: EUROGIN congress (conference abstract), Lisbon, Portugal, 8–11 May 2011
47. M.GottvallT.TydenA.T.Hoglund. Knowledge of human papillomavirus among high school students can be increased by an educational intervention. Int J STD AIDS2010; 21: 558–562.
48. A.T.HoglundT.TydenA.K.Hannerfors. Knowledge of human papillomavirus and attitudes to vaccination among Swedish high school students. Int J STD AIDS2009; 20: 102–107.
49. K.SundstromT.N.TranC.Lundholm. Acceptability of HPV vaccination among young adults aged 18–30 years – a population based survey in Sweden. Vaccine2010; 28: 7492–7500.
50. M.GottvallM.LarssonA.T.Höglund. High HPV vaccine acceptance despite low awareness among Swedish upper secondary school students. Eur J Contracept Reprod Health Care2009; 14: 399–405.
51. Gottvall M, Larsson M, Hoglund AT, et al. Knowledge of HPV among Swedish upper secondary school students. In: EUROGIN congress (conference abstract), Monte Carlo, Monaco, 17–20 February 2010
52. C.H.LenselinkC.E.SchmeinkW.J.G.Melchers. Young adults and acceptance of the human papillomavirus vaccine. Public Health2008; 122: 1295–1301.
53. H.M.van KeulenW.OttenR.A.C.Ruiter. Determinants of HPV vaccination intentions among Dutch girls and their mothers: a cross-sectional study. BMC Public Health2013; 13: 111–111.
54. Mollers M, Lubbers K, Spoelstra K, et al. Equity in HPV vaccination uptake? International papillomavirus conference (conference abstract), San Juan, Puerto Rico, 30 November–6 December 2012
55. Steens A. Participation in the two cervical cancer prevention programmes in the Netherlands. European Centre for Disease Prevention and Control [presentation], http://ecdc.europa.eu/en/escaide/materials/presentations/escaide2011_session_11_3_steens.pdf (2011, accessed 30 September 2014)
56. F.Mehu-ParantR.RouzierJ.M.Soulat. Eligibility and willingness of first-year students entering university to participate in a HPV vaccination catch-up program. Eur J Obstetr Gynecol Reprod Biol2010; 148: 186–190.
57. Lutringer-Magnin D, Kalecinski J, Barone G, et al. HPV vaccination: knowledge, practice and behavioural intentions about prevention. In: EUROGIN congress (conference abstract), Lisbon, Portugal, 8–11 May 2011
58. Sabiani L, Carcopino X, Bremond A, et al. HPV prophylactic vaccine coverage in France: results of a survey among high school and university students in Marseilles' area. In: EUROGIN congress (conference abstract), Lisbon, Portugal, 8–11 May 2011
59. E.M.DonadikiR.Jimenez-GarciaV.Hernandez-Barrera. Knowledge of the HPV vaccine and its association with vaccine uptake among female higher-education students in Greece. Human Vaccines Immunother2013; 9: 300–305.
60. E.M.DonadikiR.Jimenez-GarciaV.Hernandez-Barrera. Human papillomavirus vaccination coverage among Greek higher education female students and predictors of vaccine uptake. Vaccine2012; 30: 6967–6970.
61. Deligeoroglou E, Vrachnis N, Drakakis P, et al. Estimation of sexual education level in a Hellenic vaccinated population against HPV infection from a nationwide recording vaccination network. In: EUROGIN congress (conference abstract), Monte Carlo, Monaco, 17–20 February 2010
62. P.StockerM.DehnertM.Schuster. Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010. Human Vaccines Immunother2013; 9: 74–82.
63. S.BlodtC.HolmbergJ.Muller-Nordhorn. Human papillomavirus awareness, knowledge and vaccine acceptance: a survey among 18–25 year old male and female vocational school students in Berlin, Germany. Eur J Publ Health2012; 22: 808–813.
64. E.MarekT.DergezG.Rebek-Nagy. Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary. Vaccine2011; 29: 8591–8598.
65. P.DursunB.AltuntasE.Kuscu. Women's knowledge about human papillomavirus and their acceptance of HPV vaccine. Aust N Z J Obstetr Gynaecol2009; 49: 202–206.
66. R.DurusoyM.YamazhanM.I.Tasbakan. HPV vaccine awareness and willingness of first-year students entering university in Western Turkey. Asian Pacific J Cancer Prevent2010; 11: 1695–1701.
67. G.L.Mortensen. Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: a qualitative and quantitative study. BMC Publ Health2010; 10: 68–68.
68. S.C.WoodhallM.LehtinenT.Verho. Anticipated acceptance of HPV vaccination at the baseline of implementation: a survey of parental and adolescent knowledge and attitudes in Finland. J Adolesc Health2007; 40: 466–469.
69. O'Connor M, Murphy JC, Sharp L, et al. Women's views of HPV vaccination in Ireland: findings from a national population survey. In: EUROGIN congress (conference abstract), Lisbon, Portugal, 8–11 May 2011
70. C.ChelimoT.A.WouldesL.D.Cameron. Human papillomavirus (HPV) vaccine acceptance and perceived effectiveness, and HPV infection concern among young New Zealand university students. Sex Health2010; 7: 394–396.
71. L.A.V.MarlowG.D.ZimetK.J.McCaffery. Knowledge of human papillomavirus (HPV) and HPV vaccination: an international comparison. Vaccine2013; 31: 763–769.
72. Canfell K, Egger S, Darlington Brown J, et al. Inequalities in uptake within the Australian National HPV vaccination program. In: International papillomavirus conference (conference abstract), Berlin, Germany, 17–22 September 2011
73. N.T.BrewerC.L.CuiteJ.E.Herrington. Risk compensation and vaccination: Can getting vaccinated cause people to engage in risky behaviors?Ann Behav Med2007; 34: 95–99.
74. H.L.BowyerA.S.ForsterL.A.Marlow. Predicting human papillomavirus vaccination behaviour among adolescent girls in England: results from a prospective survey. J Fam Plann Reprod Health Care2014; 40: 14–22.
75. B.T.HansenS.K.KjaerL.Arnheim-Dahlstrom. Human papillomavirus (HPV) vaccination and subsequent sexual behaviour: evidence from a large survey of Nordic women. Vaccine2014; 32: 4945–4953.
76. Public Health England. Table 11a (i): number of anogenital warts (first episode) diagnoses in England, 2003 – 2012, http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1296688631354 (2013, accessed 28 August 2013)
77. R.Howell-JonesK.SoldanS.Wetten. Declining genital warts in young women in England associated with HPV 16/18 vaccination: an ecological study. J Infect Dis2013; 208: 1397–1403.
78. D.MesherK.SoldanR.Howell-Jones. Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England. Vaccine2013; 32: 26–32.
79. Clarke E, Board C, Patel N, et al. Why are anogenital warts diagnoses decreasing in the UK – bivalent HPV vaccine cross protection or failure to examine? (WP119); 2014 STD prevention conference, https://cdc.confex.com/cdc/std2014/webprogram/Paper34452.html (2014, accessed 5 August 2014)
80. H.AliB.DonovanH.Wand. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ2013; 346: f2032–f2032.
81. Miyamoto K and Chevalier A. “Education and health”, improving health and social cohesion through education, http://www.oecd-ilibrary.org/education/improving-health-and-social-cohesion-through-education/education-and-health_9789264086319-6-en (2010, accessed 28 August 2013)
82. J.ShepherdG.PeersmanR.Weston. Cervical cancer and sexual lifestyle: a systematic review of health education interventions targeted at women. Health Educ Res2000; 15: 681–694.
83. Department of Health. Change4lLife, one year on, http://www.google.co.uk/url?sa=t&rct=j&q=change%20for%20life%20campaign%20success&source=web&cd=4&ved=0CE8QFjAD&url=http%3A%2F%2Fwww.physicalactivityandnutritionwales.org.uk%2FDocuments%2F740%2FDH_summaryof_change4lifeoneyearon.pdf&ei=KP8dUuyiJ8-M0wXii4EI&usg=AFQjCNGv_pqELgvMMy-yei1rdRimdnq0Iw (2010, accessed 28 August 2013)
84. Bullmore J and Watkins S. Department for transport: how thirty years of drink drive communications saved almost 2,000 lives. Institute of Practitioners in Advertising, Gold, IPA Effectiveness Awards, https://gcn.civilservice.gov.uk/wp-content/uploads/2012/12/Department_for_Transport_How_thirty_years_of_drink_drive_communications_saved.pdf (2012, accessed 30 September 2014)
85. Department for Education. Personal, social, health and economic (PSHE) education, https://www.gov.uk/government/publications/personal-social-health-and-economic-education-pshe/personal-social-health-and-economic-pshe-education (2013, accessed 25 September 2013)
86. Public Health England and Hoskins A. The National perspective –Public Health England’s vision, mission and priorities, www.closerprogramme.co.uk/wordpress/wp…/AH-Closer-May2013.pdf (2013, accessed 25 September 2013)
87. R.A.BednarczykR.DavisK.Ault. Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds. Pediatrics2012; 130: 798–805.
88. N.T.Ratanasiripong. A review of human papillomavirus (HPV) infection and HPV vaccine-related attitudes and sexual behaviors among college-aged women in the United States. J Am Coll Health2012; 60: 461–470.